Experimental infection of macaques with human metapneumovirus induces transient protective immunity

Bernadette G van den Hoogen1, Sander Herfst1, Miranda de Graaf1

  • 1Department of Virology, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, The Netherlands.

Insights

Natural human metapneumovirus (hMPV) infection provides temporary protection against reinfection. Immunity wanes significantly within months, indicating transient protective immunity following hMPV illness.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Human metapneumovirus (hMPV), a Paramyxoviridae family member, causes acute respiratory illness.
  • Two primary hMPV lineages circulate globally, leading to frequent reinfections.
  • The duration and effectiveness of immunity following natural hMPV infection remain unclear.

Purpose of the Study:

  • To investigate the protective immunity induced by experimental hMPV infection in cynomolgus macaques.
  • To assess the durability of protection against homologous and heterologous hMPV reinfection at various time points.
  • To understand the impact of primary infection on subsequent viral shedding and antibody responses.

Main Methods:

  • Cynomolgus macaques were inoculated with prototype hMPV viruses from the two main lineages.
  • Animals received homologous viral challenges at 4, 6, and 12 weeks post-primary infection.
  • A separate group received multiple inoculations and was challenged with homologous or heterologous virus 8 months later.

Main Results:

  • Primary hMPV infection induced virus shedding and neutralizing antibody responses, with higher titers against homologous strains.
  • Complete protection from homologous reinfection occurred within 6 weeks, partial protection at 12 weeks.
  • Protection waned to undetectable levels by 8 months post-infection, regardless of prior homologous or heterologous exposure.

Conclusions:

  • Experimental hMPV infection induces transient protective immunity in macaques.
  • The level and durability of protection decrease significantly over time.
  • Further research is needed to understand long-term immunity and vaccine strategies for hMPV.

Related Concept Videos